FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Equine veterinary journal2015; 48(3); 290-298; doi: 10.1111/evj.12451

Prognosis and impact of equine recurrent uveitis.

Abstract: Equine recurrent uveitis (ERU) is a leading cause of vision loss in horses. Objective: To assess the prognosis and impact of ERU on affected horses and their owners by evaluating the signalment, treatment and outcome (including the loss of use, vision assessment and economic loss). Methods: Retrospective impact study. Methods: Medical records of horses presenting to the North Carolina State University Veterinary Health Complex (NCSU-VHC) with ERU between 1999 and 2014 were reviewed. Signalment, clinical signs, ophthalmic examination findings, treatments and outcomes were evaluated. Owner questionnaires were completed regarding vision, job/role, monetary value, diagnostic and treatment costs, concurrent illness and outcomes. Results: Records of 224 horses (338 eyes) with ERU were reviewed. There was an overrepresentation of Appaloosas (54; 24.1%), Hanoverians (11; 4.9%) and other Warmbloods (13; 5.8%). Ninety-six eyes (28.4%) were diagnosed as blind and 38 eyes (11.2%) with glaucoma on initial evaluation. Leptospirosis titres of serum and/or aqueous humour were obtained in 88 horses and were positive in 40 horses (45.5%), with L. pomona being the most frequently isolated serovar. Globe loss at the NCSU-VHC occurred in 41 ERU eyes (12.1% of total). Owner questionnaires were evaluated in 194 horses (86.6%) and 91 horses (46.9%) were reported blind in the affected eye(s). Fifty-seven horses (29.4%) did not return to their previous role, while 61 (31.4%) performed at a reduced level. Equine recurrent uveitis decreased the monetary value of 164 horses. Twenty-nine horses (14.9%) were euthanised and 37 (19.1%) underwent change in ownership as a direct result of ERU. Conclusions: The impact of ERU is attributed to the high frequency of blindness, globe loss and loss of function. Euthanasia and change of ownership are common sequelae to the progressive nature of ERU. These factors, along with financial costs of the disease, have a significant impact on affected horses and their owners.
© 2015 EVJ Ltd.
Get Full Text
Publication Date: 2015-07-15 PubMed ID: 25891653DOI: 10.1111/evj.12451Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper discusses a study conducted on equine recurrent uveitis (ERU), a common cause of vision loss in horses. The study aimed to assess the disease’s impact on the affected horses and their owners by examining their medical history, treatments used, and outcomes. The study showed that the disease leads to a significant loss of vision, functionality, and in some cases, results in euthanasia or change of ownership.

Methodology

  • The researchers conducted a retrospective impact study spanning from 1999 to 2014 by reviewing medical records of horses that presented with ERU at North Carolina State University Veterinary Health Complex (NCSU-VHC).
  • Details like ultimate outcome, signalment, clinical symptoms, results of ophthalmic examinations, and administered treatments were evaluated.
  • Additionally, owner questionnaires were completed to gather information about the horse’s vision status, job/role, cost implications, concurrent illnesses, and other outcomes.

Results

  • The study reviewed the records of 224 horses, with 338 affected eyes.
  • On initial evaluation, 96 eyes were diagnosed as blind, and 38 eyes had glaucoma.
  • A disproportionate number of ERU cases were found in Appaloosa, Hanoverian, and other Warmblood breeds.
  • Serum and aqueous humour leptospirosis titres were taken from 88 horses, and 40 were found to be positive. L.pomona was the most common isolate.
  • Globe loss at the NCSU-VHC occurred in 41 ERU affected eyes. Owner questionnaires for 194 horses showed that almost half were blind in the affected eye(s). Additionally, over 30% of horses performed at a reduced level post-ERU.
  • The disease also led to diminished monetary value of 164 horses.
  • As a direct result of ERU, 29 horses were euthanised, and 37 underwent change in ownership.

Conclusions

  • The study concluded that ERU has a significant impact due to the high frequency of blindness, globe loss, and loss of function it causes.
  • Euthanasia and change in ownership were common due to ERU’s progressive nature.
  • The financial burden imposed by the disease also has a significant impact on affected horses and their owners.

Cite This Article

APA
Gerding JC, Gilger BC. (2015). Prognosis and impact of equine recurrent uveitis. Equine Vet J, 48(3), 290-298. https://doi.org/10.1111/evj.12451

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 48
Issue: 3
Pages: 290-298

Researcher Affiliations

Gerding, J C
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, USA.
Gilger, B C
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, USA.

MeSH Terms

  • Animals
  • Female
  • Horse Diseases / epidemiology
  • Horse Diseases / pathology
  • Horse Diseases / therapy
  • Horses
  • Male
  • Retrospective Studies
  • Risk Factors
  • Southeastern United States
  • Uveitis / epidemiology
  • Uveitis / pathology
  • Uveitis / therapy
  • Uveitis / veterinary

Citations

This article has been cited 38 times.
  1. Young KAS, Schnabel LV, Gilger BC. Cell and Gene Therapy in Equine Ocular Disease. Vet Ophthalmol 2026 Mar;29(2):e70151.
    doi: 10.1111/vop.70151pubmed: 41623202google scholar: lookup
  2. Kirmse L, Thieme K, Doherr MG, Eule JC. Evaluation of Laboratory Techniques for the Diagnosis of Leptospira-Associated Equine Recurrent Uveitis (ERU) With Focus on the Goldmann-Witmer Coefficient. Vet Ophthalmol 2026 Jan;29(1):e70132.
    doi: 10.1111/vop.70132pubmed: 41518147google scholar: lookup
  3. Sprenzel CJ, Amann B, Deeg CA, Degroote RL. Glycan Signatures on Neutrophils in an Equine Model for Autoimmune Uveitis. Biomolecules 2025 Oct 12;15(10).
    doi: 10.3390/biom15101444pubmed: 41154673google scholar: lookup
  4. Kingsley NB, Sandmeyer L, Dwyer A, Langefeld CD, McMullen RJ Jr, McCue M, Lassaline M, Bellone RR. A genome-wide investigation of insidious uveitis in Appaloosa horses. BMC Genomics 2025 Oct 9;26(1):904.
    doi: 10.1186/s12864-025-12099-3pubmed: 41068571google scholar: lookup
  5. Tucker-Retter EK, Yamagata M, Gilger B, Oh A. Retrospective Assessment of Carbonic Anhydrase Inhibitors in Topical or Episcleral Implant Form for the Treatment of Equine Glaucoma. Vet Ophthalmol 2025 Nov;28(6):977-982.
    doi: 10.1111/vop.70086pubmed: 40983962google scholar: lookup
  6. Hardefeldt L, Thomas K, Page S, Norris J, Browning G, El Hage C, Stewart A, Gilkerson J, Muscatello G, Verwilghen D, van Galen G, Bauquier J, Cuming R, Reynolds B, Whittaker C, Wilkes E, Clulow J, Burden C, Begg L. Antimicrobial prescribing guidelines for horses in Australia. Aust Vet J 2025 Dec;103(12):781-889.
    doi: 10.1111/avj.70003pubmed: 40903020google scholar: lookup
  7. Martin de Bustamante MG, Plummer CE, Caddey B, Gomez DE. The effect of topical antibiotic or antibiotic-corticosteroid treatment on the ocular surface microbiota of healthy horses. Front Microbiol 2025;16:1535095.
    doi: 10.3389/fmicb.2025.1535095pubmed: 40831630google scholar: lookup
  8. Ing ST, Pinard CL, James-Jenks EM, Leis ML. A retrospective survey of equine ocular diseases evaluated at a referral hospital in Ontario (2011 to 2021). Can Vet J 2025 Mar;66(3):308-317.
    pubmed: 40070935
  9. Fleischer AB, Amann B, von Toerne C, Degroote RL, Schmalen A, Weißer T, Hauck SM, Deeg CA. Differential Expression of ARG1 and MRC2 in Retinal Müller Glial Cells During Autoimmune Uveitis. Biomolecules 2025 Feb 14;15(2).
    doi: 10.3390/biom15020288pubmed: 40001591google scholar: lookup
  10. Stafford LS, Plummer CE, Smith WC, Gibson DJ, Sharma J, Vicuna V, Diakite S, Larkin J 3rd. A peptide mimic of SOCS1 modulates equine peripheral immune cells in vitro and ocular effector functions in vivo: implications for recurrent uveitis. Front Immunol 2024;15:1513157.
    doi: 10.3389/fimmu.2024.1513157pubmed: 39867889google scholar: lookup
  11. Gerras J, Young K, Roberts D, Waldman G, Salmon JH, Gilger BC. Uveitis and blindness in a closed herd of Equidae following leptospiral infection. Front Vet Sci 2024;11:1504990.
    doi: 10.3389/fvets.2024.1504990pubmed: 39834922google scholar: lookup
  12. Young K, Hasegawa T, Vridhachalam N, Henderson N, Salmon JH, McCall TF, Hirsch ML, Gilger BC. Ocular toxicity, distribution, and shedding of intravitreal AAV-eqIL-10 in horses. Mol Ther Methods Clin Dev 2024 Dec 12;32(4):101360.
    doi: 10.1016/j.omtm.2024.101360pubmed: 39703903google scholar: lookup
  13. Ramsay L, Eberhardt C, Schoster A. Acute leptospirosis in horses: A retrospective study of 11 cases (2015-2023). J Vet Intern Med 2024 Sep-Oct;38(5):2729-2738.
    doi: 10.1111/jvim.17184pubmed: 39194176google scholar: lookup
  14. Shnaiderman-Torban A, Pe'er O, Gustafsson K, Tatz A, Brizi M, Soback S, Abu Ahmad W, Magen R, Ofri R, Kelmer G. The effect of systemic acetazolamide administration on intraocular pressure in healthy horses-A preliminary study. Vet Ophthalmol 2025 Jan;28(1):66-72.
    doi: 10.1111/vop.13240pubmed: 38839562google scholar: lookup
  15. Scharre A, Scholler D, Gesell-May S, Müller T, Zablotski Y, Ertel W, May A. Comparison of veterinarians and a deep learning tool in the diagnosis of equine ophthalmic diseases. Equine Vet J 2025 Jan;57(1):47-53.
    doi: 10.1111/evj.14087pubmed: 38567426google scholar: lookup
  16. Morén S, Kallberg M, Strom L. Equine uveitis: Outcome and adverse effects after one or two intravitreal low-dose gentamicin injections. Equine Vet J 2025 Jan;57(1):160-168.
    doi: 10.1111/evj.14056pubmed: 38329024google scholar: lookup
  17. Degroote RL, Schmalen A, Hauck SM, Deeg CA. Unveiling Differential Responses of Granulocytes to Distinct Immunostimulants with Implications in Autoimmune Uveitis. Biomedicines 2023 Dec 20;12(1).
    doi: 10.3390/biomedicines12010019pubmed: 38275380google scholar: lookup
  18. Cassano JM, Leonard BC, Martins BC, Vapniarsky N, Morgan JT, Dow SW, Wotman KL, Pezzanite LM. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis. Front Vet Sci 2023;10:1293199.
    doi: 10.3389/fvets.2023.1293199pubmed: 38162475google scholar: lookup
  19. Arrieta-Bechara CE, Carrascal-Maldonado AY. Ocular leptospirosis: a review of current state of art of a neglected disease. Rom J Ophthalmol 2022 Oct-Dec;66(4):282-288.
    doi: 10.22336/rjo.2022.53pubmed: 36589326google scholar: lookup
  20. Padjasek M, Qasem B, Cisło-Pakuluk A, Marycz K. Cyclosporine A Delivery Platform for Veterinary Ophthalmology-A New Concept for Advanced Ophthalmology. Biomolecules 2022 Oct 20;12(10).
    doi: 10.3390/biom12101525pubmed: 36291734google scholar: lookup
  21. Ekstrand C, Michanek P, Gehring R, Sundell A, Källse A, Hedeland M, Ström L. Plasma atropine concentrations associated with decreased intestinal motility in horses. Front Vet Sci 2022;9:951300.
    doi: 10.3389/fvets.2022.951300pubmed: 36118347google scholar: lookup
  22. Hoffmann ALC, Hauck SM, Deeg CA, Degroote RL. Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro. Int J Mol Sci 2022 Aug 23;23(17).
    doi: 10.3390/ijms23179555pubmed: 36076947google scholar: lookup
  23. Crabtree E, Uribe K, Smith SM, Roberts D, Salmon JH, Bower JJ, Song L, Bastola P, Hirsch ML, Gilger BC. Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy. PLoS One 2022;17(8):e0270972.
    doi: 10.1371/journal.pone.0270972pubmed: 35980983google scholar: lookup
  24. Wollanke B, Gerhards H, Ackermann K. Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis. Microorganisms 2022 Feb 7;10(2).
    doi: 10.3390/microorganisms10020387pubmed: 35208842google scholar: lookup
  25. Ackermann K, Kenngott R, Settles M, Gerhards H, Maierl J, Wollanke B. In Vivo Biofilm Formation of Pathogenic Leptospira spp. in the Vitreous Humor of Horses with Recurrent Uveitis. Microorganisms 2021 Sep 9;9(9).
    doi: 10.3390/microorganisms9091915pubmed: 34576809google scholar: lookup
  26. Barfüßer C, Wiedemann C, Hoffmann ALC, Hirmer S, Deeg CA. Altered Metabolic Phenotype of Immune Cells in a Spontaneous Autoimmune Uveitis Model. Front Immunol 2021;12:601619.
    doi: 10.3389/fimmu.2021.601619pubmed: 34385998google scholar: lookup
  27. Ström L, Dalin F, Domberg M, Stenlund C, Bondesson U, Hedeland M, Toutain PL, Ekstrand C. Topical ophthalmic atropine in horses, pharmacokinetics and effect on intestinal motility. BMC Vet Res 2021 Apr 7;17(1):149.
    doi: 10.1186/s12917-021-02847-4pubmed: 33827566google scholar: lookup
  28. Martin de Bustamante M, Gomez D, MacNicol J, Hamor R, Plummer C. The Fecal Bacterial Microbiota in Horses with Equine Recurrent Uveitis. Animals (Basel) 2021 Mar 9;11(3).
    doi: 10.3390/ani11030745pubmed: 33803123google scholar: lookup
  29. Degroote RL, Deeg CA. Immunological Insights in Equine Recurrent Uveitis. Front Immunol 2020;11:609855.
    doi: 10.3389/fimmu.2020.609855pubmed: 33488614google scholar: lookup
  30. Fagre AC, Mayo CE, Pabilonia KL, Landolt GA. Seroprevalence of Leptospira spp. in Colorado equids and association with clinical disease. J Vet Diagn Invest 2020 Sep;32(5):718-721.
    doi: 10.1177/1040638720943155pubmed: 32715980google scholar: lookup
  31. Wiedemann C, Amann B, Degroote RL, Witte T, Deeg CA. Aberrant Migratory Behavior of Immune Cells in Recurrent Autoimmune Uveitis in Horses. Front Cell Dev Biol 2020;8:101.
    doi: 10.3389/fcell.2020.00101pubmed: 32211402google scholar: lookup
  32. Crabtree E, Song L, Llanga T, Bower JJ, Cullen M, Salmon JH, Hirsch ML, Gilger BC. AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis. Sci Rep 2019 Dec 27;9(1):19864.
    doi: 10.1038/s41598-019-56462-3pubmed: 31882729google scholar: lookup
  33. Saldinger LK, Nelson SG, Bellone RR, Lassaline M, Mack M, Walker NJ, Borjesson DL. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro. Vet Ophthalmol 2020 Jan;23(1):160-170.
    doi: 10.1111/vop.12704pubmed: 31441218google scholar: lookup
  34. Fischer BM, McMullen RJ Jr, Reese S, Brehm W. Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results. BMC Vet Res 2019 Jan 16;15(1):29.
    doi: 10.1186/s12917-018-1722-7pubmed: 30651102google scholar: lookup
  35. Trimble AC, Blevins CA, Beard LA, Deforno AR, Davis EG. Seroprevalence, frequency of leptospiuria, and associated risk factors in horses in Kansas, Missouri, and Nebraska from 2016-2017. PLoS One 2018;13(10):e0206639.
    doi: 10.1371/journal.pone.0206639pubmed: 30372498google scholar: lookup
  36. Gialletti R, Marchegiani A, Valeriani T, Nannarone S, Beccati F, Fruganti A, Laus F. A survey of ocular ultrasound abnormalities in horse: 145 cases. J Ultrasound 2018 Mar;21(1):53-59.
    doi: 10.1007/s40477-018-0284-7pubmed: 29492841google scholar: lookup
  37. Paschalis-Trela K, Cywińska A, Trela J, Czopowicz M, Kita J, Witkowski L. The prevalence of ocular diseases in polish Arabian horses. BMC Vet Res 2017 Nov 7;13(1):319.
    doi: 10.1186/s12917-017-1252-8pubmed: 29115950google scholar: lookup
  38. Sandmeyer LS, Bauer BS, Feng CX, Grahn BH. Equine recurrent uveitis in western Canadian prairie provinces: A retrospective study (2002-2015). Can Vet J 2017 Jul;58(7):717-722.
    pubmed: 28698690
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.